High-Potency Mydriatic Eye Drops Franchise in Ahmedabad

Phenylephrine 5% Eye Drops Supplier in Mumbai

Advanced Ophthalmic Pupil Dilation Distributor in Delhi

Mydriatic Eye Drops PCD Pharma Franchise in Bangalore

Phenylephrine Eye Drops Stockist in Hyderabad
Ophthalmic High-Potency Mydriatic Eye Drops Manufacturer & Exporter in Chandigarh

Home/Products /phenylephrine-5-w-v-eye-drop

Phenycure Plus Eye Drops

Composition : Phenylephrine (5% w/v) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹0/-

Phenycure Plus Eye Drops contain Phenylephrine (5% w/v), a high-potency mydriatic ophthalmic solution used for enhanced pupil dilation during complex diagnostic exams and surgical procedures. Its formulation ensures rapid, controlled, and safe dilation for accurate evaluation and treatment.

Phenylephrine works by stimulating the iris dilator muscles, providing precise and long-lasting pupil enlargement for retinal assessments, intraocular surgery, and other ophthalmic procedures. The 5% strength offers enhanced efficacy for advanced clinical requirements.

Clinically, Phenycure Plus Eye Drops allow efficient procedural workflow while maintaining patient safety and comfort, making them ideal for ophthalmologists handling specialized or high-demand cases.

From a business perspective, Phenycure Plus Eye Drops strengthen the high-potency mydriatic segment, offering steady prescription demand, repeat orders, and high-margin franchise opportunities. Its clinical trust and prescriber confidence make it a profitable addition for PCD pharma distributors nationwide.

Read More

About the Product

Phenycure Plus Eye Drops contain Phenylephrine (5% w/v), a high-potency mydriatic ophthalmic solution used for enhanced pupil dilation during complex diagnostic exams and surgical procedures. Its formulation ensures rapid, controlled, and safe dilation for accurate evaluation and treatment.

Phenylephrine works by stimulating the iris dilator muscles, providing precise and long-lasting pupil enlargement for retinal assessments, intraocular surgery, and other ophthalmic procedures. The 5% strength offers enhanced efficacy for advanced clinical requirements.

Clinically, Phenycure Plus Eye Drops allow efficient procedural workflow while maintaining patient safety and comfort, making them ideal for ophthalmologists handling specialized or high-demand cases.

From a business perspective, Phenycure Plus Eye Drops strengthen the high-potency mydriatic segment, offering steady prescription demand, repeat orders, and high-margin franchise opportunities. Its clinical trust and prescriber confidence make it a profitable addition for PCD pharma distributors nationwide.

Common side effects may include temporary blurred vision, stinging or burning sensation, light sensitivity, or mild eye irritation. Rarely, systemic effects such as increased blood pressure, headache, tachycardia, or allergic reactions may occur, especially in sensitive patients.

Phenycure Plus Eye Drops are indicated for pupil dilation during ophthalmic diagnostic procedures, such as fundoscopy, retinoscopy, and refraction testing, and for temporary relief of ocular redness. Use is recommended under the supervision of an ophthalmologist.

Use Phenycure Plus Eye Drops strictly under ophthalmologist guidance. Avoid touching the dropper tip to the eye to prevent contamination. Do not use in infants, patients with severe cardiovascular disease, or without medical supervision. Discontinue and consult a doctor if severe irritation, unusual systemic symptoms, or allergic reactions appear.

Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation